MED
Get informed when a big investor buys or sells
+ FollowUndervalued by 240.4% based on the discounted cash flow analysis.
| Market cap | $139.32 Million |
|---|---|
| Enterprise Value | $83.89 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.7 |
| Beta | 0.57 |
| Outstanding Shares | 11,006,000 |
| P/E Ratio | -6.89 |
|---|---|
| PEG | -3.94 |
| Price to Sales | 0.39 |
| Price to Book Ratio | 0.72 |
| Enterprise Value to Revenue | 0.24 |
| Enterprise Value to EBIT | -5.97 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0.19 |
| Debt to Equity | 0.08 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0351▼ 4.70% |
|---|---|
| Total Calls | 1,598,300▲ 53.83% |
| Total Puts | 56,100▼ 34.23% |
Holdings and activity of institutional investors.
| Ownership % | 78.34%▲ 4.96% |
|---|---|
| Total Invested | $87.64M▲ 1.31% |
| Investors Holding | 119▲ 6.00% |
No data
Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and ...